Stocks In News: Stereotaxis Inc (NASDAQ:STXS), Coronado Biosciences Inc (NASDAQ:CNDO), China Techfaith Wireless Comm. Tech. Ltd (NASDAQ:CNTF), Pacific Biosciences of California (NASDAQ:PACB)
Stereotaxis Inc (NASDAQ:STXS) shares surged 29.29% and closed at $9.49. The company on July 29 announced that it has been granted 510(k) clearance by the Food and Drug Administration (FDA) to market its Vdrive™ Robotic Navigation System with V-Sono™ Intracardiac Echocardiography (ICE) catheter manipulator in the U.S. This represents the first FDA clearance for the Vdrive family of products, which has been utilized in Europe since 2011.
Coronado Biosciences Inc (NASDAQ:CNDO) shares gained 21.90% to $10.02. The company on August 5 announced today its financial results for the second quarter ended June 30, 2013. The company reported a net loss of $10.7 million and $19.5 million for the three and six months ended June 30, 2013, respectively, compared to a net loss of $6.5 million and $13.0 million for the three and six months ended June 30, 2012, respectively.
China Techfaith Wireless Comm. Tech. Ltd (NASDAQ:CNTF) shares gained 17.80% to $1.39. The company announced that it will hold a conference call to discuss the Company’s financial results for the second quarter 2013 and its business outlook. The dial-in number for the live audio call, which will begin on Tuesday, August 20, 2013 at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Tuesday, August 20, 2013 in Beijing), is +1-857-244-7556 or +1-877-474-9503 .
Pacific Biosciences of California (NASDAQ:PACB) shares jumped 16.84% and closed at $3.33 in the last trading session. The company on August 1 announced financial results for the second quarter ended June 30, 2013. Revenue for the second quarter of 2013 totaled $6.0 million, compared to $5.6 million for the first quarter of 2013.
Cash and investments at June 30, 2013 totaled $107.0 million compared to $112.3 million at March 31, 2013. The decrease in cash and investments during the period reflects cash use of $16.6 million partially offset by $11.3 million of cash received from the sale of stock.